TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | 1 | 3 | -6 | -12 | -11 | -20 | -8 |
| S | %wins | 50 | 0 | 50 | 100 | 100 | 50 | 58 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/10/21 16:57 | 2/19/21 | LCI | Lannett Co Inc | DE | Health | Drug | Pharmaceutical Preparations | Taveira Paul | PA | D | S | -197 | 6.58 | 0 | -30 | -33 | 60 | D | |||||||||||||||
5/21/20 16:17 | 5/19/20 | LCI | Lannett Co Inc | DE | Health | Drug | Pharmaceutical Preparations | Taveira Paul | PA | D | S | -217 | 7.22 | 0 | -30 | -37 | 51 | D | |||||||||||||||
3/10/15 17:37 | 3/6/15 | LCI | Lannett Co Inc | DE | Health | Drug | Pharmaceutical Preparations | Taveira Paul | PA | D | S | -158 | 63.07 | 33 | -3 | -14 | 16 | D | 582 | 46 | 67 | 36 | 32 | 6 | -1 | 4 | 1 | 3 | 10 | -10 | -14 | -62 | |
6/18/14 17:33 | 6/16/14 | LCI | Lannett Co Inc | DE | Health | Drug | Pharmaceutical Preparations | Taveira Paul | PA | D | S | -47 | 46.94 | 33 | -1 | -6 | 16 | D | 999 | 301 | 62 | 7 | 33 | 15 | 3 | -1 | 0 | 2 | -22 | -14 | -7 | 23 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |